Select a company

Go

Company Stage

  • Private (seed)
  • Private (post-seed)
  • Quoted

Sector

  • Biotech
  • Healthcare
  • Cleantech
  • Technology
  • Other

University

  • University of Bath
  • University of Bristol
  • University of Cardiff
  • University of Glasgow
  • University of Leeds
  • King's College London
  • Queen Mary, University of London
  • University of Manchester
  • University of Nottingham
  • University of Oxford
  • University of Sheffield
  • University of Southampton
  • University of Surrey
  • Swansea University
  • University of York
  • Other

Stakeholder

  • IP Group
  • IP Venture Fund
  • IP Venture Fund II
  • Top 10 Holdings
    by value
Medical Equipment & Supplies

University: Oxford

Company Stage: Private (post-seed)

Website: http://www.nanoporetech.com

Oxford Nanopore Technologies

Oxford Nanopore Technologies Ltd is developing a new generation of nanopore-based electronic systems for analysis of single molecules, including DNA, RNA and proteins. 

The MinION™ device and GridION™ system are designed to provide novel qualities in molecular sensing such as real-time data streaming, improved simplicity, efficiency and scalability of workflows and direct analysis of the molecule of interest. The devices may be used in scientific research, personalised medicine, crop science, security and defence and environmental applications. 

Supported by a broad patent portfolio, the Oxford Nanopore pipeline includes multiple generations of nanopore-based sensing technologies, including those based on both biological and solid-state nanopores.

As at 31 Dec 2013

IP Group holding

IP Venture Fund* holding

19.6%

1.2%
 

*IP Group has a 10%
economic interest in IP
Venture Fund

Holdings represent undiluted beneficial equity interest excluding debt

Oxford Nanopore Technologies

Related news

12 Aug 2014
15 Nov 2013

There is currently no news available.

More portfolio news